fig2

Figure 2. The scheme of molecular pathways and promising treatments for ENKL patients. LMP: Latent membrane protein; EBV: Epstein-Barr virus; HDAC: histone deacetylase.
Figure 2. The scheme of molecular pathways and promising treatments for ENKL patients. LMP: Latent membrane protein; EBV: Epstein-Barr virus; HDAC: histone deacetylase.
All published articles are preserved here permanently:
https://www.portico.org/publishers/oae/